#JCER
#MusicChallenge
#musicsky
#billiesmusicmonth

19. A grocery store

The retail trade, the corner shop, at humble service of plain town-folk
Fray Bentos pie: always a winner

Jethro Tull – Cosy Corner/Shunt and Shuffle
www.youtube.com/watch?v=jCEr...
Cosy Corner/Shunt and Shuffle
YouTube video by Ian Anderson - Topic
www.youtube.com
March 18, 2026 at 9:01 PM
#MusicChallenge
#JulyYouAreASong

19 – The sequel to yesterday’s song

and 40 years later Ian muses on what Gerald may have done next:

Fray Bentos pies – always a winner

Ian Anderson - Thick As A Brick 2

Gerald – A Most Ordinary Man : Cosy Corner/Shunt and Shuffle
www.youtube.com/watch?v=jCEr...
Cosy Corner/Shunt and Shuffle
YouTube video by Ian Anderson - Topic
www.youtube.com
July 18, 2025 at 9:11 PM
Share your favorite Star Trek Prodigy episode.

Like, I REALLY REALLY WANT to say "Mindwallk" ... but the JCer in me has to say "Cracked Mirror" 🥴 #setacourseforseason3 #startrek #prodigy

(reposted)
November 26, 2024 at 3:12 AM
Στην καρδιολογική, χωρίς αμφιβολία, το άσμα είναι ένα και μόνο: 💓💔❤️‍🩹

www.youtube.com/watch?v=JceR...
August 20, 2026 at 6:17 AM
📢 New Editorial in JCER: “How much do ex-US revenues make a difference for pharmaceutical investment returns?”

🔗Read here: becarispublishing.com/doi/10.57264...

#OpenAccess #JCER #IRA #Pharma #RWE #HealthPolicy #DrugPricing
How much do ex-US revenues make a difference for pharmaceutical investment returns?
becarispublishing.com
September 2, 2025 at 2:20 PM
April 17, 2025 at 1:58 AM
He has another account:

bsky.app/profile/jcer...
August 13, 2026 at 1:16 AM
Japan GDP up 3% in February, helped by exports: JCER
Exports to U.S. jump 15.2% ahead of Trump tariffs
asia.nikkei.com
April 9, 2025 at 9:45 AM
📢 New in JCER:
“Assessing healthcare resource utilization burden and unmet treatment needs in patients with Parkinson’s disease: results from a real-world study”

🔗 becarispublishing.com/doi/10.57264...

#OpenAccess #JCER #Parkinsons #RWE #QualityOfLife
Assessing healthcare resource utilization burden and unmet treatment needs in patients with Parkinson’s disease: results from a real-world study
Aim: Current Parkinson’s disease (PD) research evaluates patients with early and severe PD, but often overlooks patients with intermediate PD. This study aims to quantify unmet treatment needs, diseas...
becarispublishing.com
September 23, 2025 at 4:51 PM
📢 New in JCER: "Are you implementation ready? An alternative patient and healthcare system-centered model for pharma"

🔗 becarispublishing.com/doi/10.57264...

#OpenAccess #JCER #Pharma #PatientCentricity #HealthcareInnovation #MarketAccess
Becaris Publishing
becarispublishing.com
August 15, 2025 at 10:06 AM
📢 New in JCER: “Optimizing clinical scientific research: the cohort intervention random sampling study with historical controls”.

🔗 becarispublishing.com/doi/10.57264...

#OpenAccess #JCER #RCT #ClinicalTrials #StudyDesign #CIRSS #Methodology
Optimizing clinical scientific research: the cohort intervention random sampling study with historical controls
Randomized controlled trials (RCTs) are regarded as the highest level of evidence in medical research, but RCTs also have their drawbacks. Over the years, several alternative study designs have been i...
becarispublishing.com
September 19, 2025 at 9:13 AM
📢New article alert

New Research Article on “Health outcomes and costs in patients prescribed anticholinergic medications for overactive bladder”.

🔗Read here: becarispublishing.com/doi/10.57264...

#OpenAccess #JCER #OAB #PatientSafety #HEOR
Becaris Publishing
becarispublishing.com
December 10, 2025 at 10:45 AM
📢New article alert
New research in JCER compares etrasimod and ozanimod for ulcerative colitis treatment, with findings that could help physicians make informed decisions about treatment options.

🔗Read here: becarispublishing.com/doi/10.57264...

#UlcerativeColitis #UC #OpenAccess #JCER
Matching-adjusted indirect comparisons of efficacy outcomes between etrasimod and ozanimod for moderately to severely active ulcerative colitis
Aim: Etrasimod and ozanimod are selective sphingosine 1-phosphate receptor modulators targeting the S1P1,4,5, and S1P1,5 receptors, respectively, for the treatment of patients with moderately to sever...
becarispublishing.com
March 11, 2025 at 11:06 AM
More like
August 9, 2026 at 11:03 PM
📢 New in JCER: "Identification of treatment effect modifiers and prognostic factors in newly diagnosed and relapsed or refractory multiple myeloma"

🔗 becarispublishing.com/doi/10.57264...

#OpenAccess #JCER #MultipleMyeloma #Oncology #ClinicalTrials
Identification of treatment effect modifiers and prognostic factors in newly diagnosed and relapsed or refractory multiple myeloma
Aim: We aimed to identify variables that affect the prognosis and treatment effect in multiple myeloma (MM). Materials & methods: Published literature of randomized controlled trials (RCTs) and po...
becarispublishing.com
August 18, 2025 at 10:01 AM
📢 New in JCER: "Matching-adjusted indirect comparison of ribociclib + nonsteroidal aromatase inhibitor versus abemaciclib + endocrine therapy in hormone receptor-positive/HER2-negative early breast cancer".

Read here: 🔗 becarispublishing.com/doi/10.57264...

#OpenAccess #JCER #BreastCancer #MAIC
Becaris Publishing
becarispublishing.com
August 29, 2025 at 1:35 PM
youtube.com/watch?v=jceR... Nazi traditions…
Redstone Arsenal Oktoberfest in Huntsville Alabama
YouTube video by LaunchPad HSV
youtube.com
March 3, 2026 at 6:07 PM
📢 New in research in JCER: “Healthcare cost comparison between first-line ibrutinib and acalabrutinib in chronic lymphocytic leukemia patients in the Veterans Affairs”

🔗 becarispublishing.com/doi/10.57264...

#OpenAccess #JCER #CLL #HEOR #RWE
Becaris Publishing
becarispublishing.com
October 20, 2025 at 3:48 PM
📢New article alert

New Research article in JCER on "Considerations for emulations of randomized controlled trials using real-world data: learnings from an emulation of MONALEESA-2".

🔗Read here: becarispublishing.com/doi/10.57264...

#OpenAccess #JCER #RWD #RWE #TrialEmulation #BreastCancer
becarispublishing.com
October 31, 2025 at 12:29 PM
📢New article alert

New Systematic Review highlights the role of health economic evidence in colorectal cancer guidelines, finding that although 57% of guidelines include HEE, reporting quality varies globally.

🔗Read here: becarispublishing.com/doi/10.57264...

#ColorectalCancer #OpenAccess #JCER
February 26, 2025 at 1:46 PM
📢New article alert

New Short Report in JCER finds #elranatamab improves progression-free & overall survival compared to physician's choice of treatment for patients with triple-class exposed/refractory #MultipleMyeloma.

🔗 becarispublishing.com/doi/10.57264...

#Oncology #OpenAccess #JCER
Elranatamab versus physician’s choice of treatment in patients with triple-class exposed/refractory multiple myeloma: an updated matching-adjusted indirect comparison
Aim: Despite the availability of novel treatment options for patients with triple-class exposed/refractory multiple myeloma , there is a lack of consensus on the optimal regimen. A previous unanchored...
becarispublishing.com
April 15, 2025 at 3:31 PM